This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It’s also likely to be cheaper and not suffer the same kind of supply-chain shortages that existing therapeutics have faced. But it’s been a dramatic few weeks for the leading three drug-makers vying to usher in this … Read more
Derek Lowe, Science Magazine Keeping up with the GLP-1 area is a full time job by itself. First off, you have the recent development that these drugs are no longer considered to officially…
Researchers in China have found a gut microbe, Bacteroides vulgatus, that may regulate blood sugar. The microbe and its metabolites can stimulate GLP-1 secretion. GLP-1 is a hormone that controls blood sugar and fullness. The study showed that increasing this microbe in mice can help. This discovery may offer a natural alternative to drugs like … Read more
Between 2018 and 2022, GLP-1 RA use surged among US adults without diabetes, yet adoption remained modest. Medscape Medical News
NAUSEA, constipation, breathing problems, racing heart… the list of Ozempic side effects appears to be growing by the day. And now experts have revealed a new “incredibly common” issue that “nearly everyone” using weight loss injections will experience. instagramCelebrities including Gemma Collins and Rebel Wilson have proudly confessed to using skinny jabs to shed the … Read more
PLAINSBORO, N.J., May 2, 2025 /PRNewswire/ — Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy®…
by Daniel J Drucker Nature Reviews Drug Discovery Drucker DJ. GLP-1-based therapies for diabetes, obesity and beyond. Nat Rev Drug Discov. 2025 Apr 25. doi: 10.1038/s41573-025-01183-8. Epub ahead of print. PMID: 40281304. This review article discusses GLP-1-based therapies, highlighting their effectiveness for managing type 2 diabetes and obesity, including well-known drugs like semaglutide and tirzepatide. The text details the evolution … Read more
You may have heard of “Ozempic face” and “Ozempic butt.” Well, now there’s “Ozempic mouth” and “Ozempic feet” to describe more effects of GLP-1 receptor agonists.
New GLP-1 Survey Finds Users Cutting Restaurant Spend Last week’s GLP-1 headlines included Novo Nordisk partnering with telehealth platforms Hims & Hers, LifeMD, and Ro to offer its weight-loss drug Wegovy directly to consumers at substantial discounts, aiming to improve affordability and access. Meanwhile, Eli Lilly reported robust demand for its rival anti-obesity medication, Mounjaro. … Read more
The 50 states ranked by the Obesity Action Coalition (OAC) These sources are a collection of fact sheets from the Obesity Action Coalition (OAC), one for each of the fifty states and the District of Columbia, providing data on the impact of obesity, including state rankings, the percentage of adults classified as obese, overweight, and normal weight, and … Read more